Selective modulation of epileptic tissue by an adenosine A3 receptor-activating drug
- PMID: 39300608
- PMCID: PMC11578780
- DOI: 10.1111/bph.17319
Selective modulation of epileptic tissue by an adenosine A3 receptor-activating drug
Abstract
Background and purpose: Adenosine, through the A1 receptor (A1R), is an endogenous anticonvulsant. The development of adenosine receptor agonists as antiseizure medications has been hampered by their cardiac side effects. A moderately A1R-selective agonist, MRS5474, has been reported to suppress seizures without considerable cardiac action. Hypothesizing that this drug could act through other than A1R and/or through a disease-specific mechanism, we assessed the effect of MRS5474 on the hippocampus.
Experimental approach: Excitatory synaptic currents, field potentials, spontaneous activity, [3H]GABA uptake and GABAergic currents were recorded from rodent or human hippocampal tissue. Alterations in adenosine A3 receptor (A3R) density in human tissue were assessed by Western blot.
Key results: MRS5474 (50-500 nM) was devoid of effect upon rodent excitatory synaptic signals in hippocampal slices, except when hyperexcitability was previously induced in vivo or ex vivo. MRS5474 inhibited GABA transporter type 1 (GAT-1)-mediated γ-aminobutyric acid (GABA) uptake, an action not blocked by an A1R antagonist but blocked by an A3R antagonist and mimicked by an A3R agonist. A3R was overexpressed in human hippocampal tissue samples from patients with epilepsy that had focal resection from surgery. MRS5474 induced a concentration-dependent potentiation of GABA-evoked currents in oocytes micro-transplanted with human hippocampal membranes prepared from epileptic hippocampal tissue but not from non-epileptic tissue, an action blocked by an A3R antagonist.
Conclusion and implications: We identified a drug that activates A3R and has selective actions on epileptic hippocampal tissue. This underscores A3R as a promising target for the development of antiseizure medications.
Keywords: GABAergic transmission; adenosine A1 receptor; adenosine A3 receptor; epilepsy; hippocampus; neuronal excitability.
© 2024 The Author(s). British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society.
Conflict of interest statement
CONFLICT OF INTEREST STATEMENT
There are no competing interests.
References
-
- Alexander SPH, Christopoulos A, Davenport AP, Kelly E, Mathie AA, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Davies JA, Abbracchio MP, Abraham G, Agoulnik A, Alexander W, Al-Hosaini K, Bäck M, Baker JG, Barnes NM, … Ye RD (2023). The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors. British Journal of Pharmacology, 180, S23–S144. 10.1111/bph.16177 - DOI - PubMed
-
- Alexander SPH, Fabbro D, Kelly E, Mathie AA, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Davies JA, Amarosi L, Anderson CMH, Beart PM, Broer S, Dawson PA, Gyimesi G, Hagenbuch B, Hammond JR, Hancox JC, … Verri T (2023). The Concise Guide to PHARMACOLOGY 2023/24: Transporters. British Journal of Pharmacology, 180, S374–S469. 10.1111/bph.16182 - DOI - PubMed
-
- Alexander SPH, Mathie AA, Peters JA, Veale EL, Striessnig J, Kelly E, Armstrong JF, Faccenda E, Harding SD, Davies JA, Aldrich RW, Attali B, Baggetta AM, Becirovic E, Biel M, Bill RM, Caceres AI, Catterall WA, Conner AC, … Zhu M (2023). The Concise Guide to PHARMACOLOGY 2023/24: Ion channels. British Journal of Pharmacology, 180, S145–S222. 10.1111/bph.16181 - DOI - PMC - PubMed
-
- Alexander SPH, Roberts RE, Broughton BRS, Sobey CG, George CH, Stanford SC, Cirino G, Docherty JR, Giembycz MA, Hoyer D, Insel PA, Izzo AA, Ji Y, MacEwan DJ, Mangum J, Wonnacott S, & Ahluwalia A (2018). Goals and practicalities of immunoblotting and immunohistochemistry: A guide for submission to the British Journal of Pharmacology. British Journal of Pharmacology, 175, 407–411. 10.1111/bph.14112 - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
- Z01 DK031117/ImNIH/Intramural NIH HHS/United States
- RM11916B84D24429/Sapienza Università di Roma
- Z99 DK999999/ImNIH/Intramural NIH HHS/United States
- Italian Ministry of Health
- PRIN-PNRR 2022/Italian Ministry of University and Research
- iMM-BI-4-2022/Instituto de Medicina Molecular João Lobo Antunes
- PD/BD/150344/2019/Fundação para a Ciência e a Tecnologia
- International Society for Neurochemistry
- 952455/H2020-WIDESPREAD-05-2017-Twinning (EpiEpiNet)
- PRIN 2022/Italian Ministry of University and Research
- ZIADK031117/NIDDK Intramural Research Program
- RG12117A8697DCF1/Sapienza Università di Roma
- PTDC/MED-FAR/4834/2021/Fundação para a Ciência e a Tecnologia
- PTDC/MED-FAR/30933/2017/Fundação para a Ciência e a Tecnologia
LinkOut - more resources
Full Text Sources
Medical